Managing MSologist deficiency: the MS MDT model


By By Dr Basil Ridha, Royal Sussex County Hospital, Brighton

Background

  • Brighton and Sussex University Hospital NHS Trust (BSUH) is based at 2 main sites :
    • Royal Sussex County Hospital, Brighton
    • Princess Royal Hospital, Haywards Heath
      • Includes Hurstwood Park Neurosciences Centre
    • Provides:
      • Acute service to 0.5 Million (2012)
      • Regional neurosciences service to 1.5 Million (2012)
    • Regional neurosciences service:
      • 16 full time equivalent consultant neurologists
      • Of these 8 bases at BSUH
      • Of these, 2 have special interest in MS
    • Traditionally, all new patients with suspected MS referred to MS clinic and the:
      • Discharged back to referring neurologist if :
        • Patients do not require/qualify for DMT
        • Patients go on glatiramer acetate/ beta interferon
      • Discharged back to referring neurologist if the patient remains stable on a first line oral therapies (Aubagio/Tecfidera) for a year.
      • Remain under MS clinic only if prescribed a high efficacy therapy (Gilenya, Lemtrada, Tysabri)

Challenge

  • One of the 2 neurologists with special interest in MS left the Trust almost 2 years ago.
  • New academic neurologist with special interest in MS appointed with limited clinical commitment capacity.
  • Significant reduction in capacity to follow up existing MS patients and see new referrals.
  • Over time there has been accumulation of backlog of 500 MS patients needing follow up.
  • Patients under MS clinic:
    • Tecfidera 181
    • Copaxone 79-probably 3-4 times that number in whole of Sussex
    • Beta interferons 61-probably 3-4 times that number in whole of Sussex
    • Teriflunomide 70
    • Alemtuzumab 129 (58 second round)
    • Fingolimod 117
    • Tysabri 101
  • About 580 MS patients on oral or infusion DMT
  • So far no replacement appointed to replace the full time neurologist with special interest in MS
  • Remaining MS neurologist and academic neurologist just doing MS clinics, with little general neurology work, to clear backlog of follow ups

Interim solution

  • MDT model:
    • All referrals from general neurologists discussed at weekly MS MDT (tagged to neuroradiology meeting) attended by :
      • Neurologist with special in MS
      • Neuroradiologist
      • 3 hospital based MS Nurse specialists (looking after oral and infusion DMTs)
      • Sometimes community nurses
    • If patient goes on therapy other than infusion treatment or Gilenya, then all care remains under referring neurologist. Otherwise, joint care.
  • MDT model for referrals started in past 6 weeks
  • Over the past 6 weeks, I have referred 5 patients:
    • 3 offered first line MDT :
      • 1 patient gone on Lemtrada
      • 1 patient considering either Tecfidera or Copaxone but undecided
      • 1 patient gone on Aubagio
    • 1 patient felt not eligible as probably PPMS
    • 1 inpatient. Diagnosis still uncertain if highly active MS or NMO. Under joint care for now

Challenges (to the referring general neurologist)

  • Time to attend MS MDT
  • Additional admin time eg liaising with MS therapy nurses
  • Blueteq form
  • Record EDSS yearly when seen in general neurology clinic

Advantages (to the referring general neurologist)

  • Quicker time from diagnosis to therapy
  • Sense of involvement and “personal value”
  • Feel more part of MS team
  • Reskilling in MS emerging therapies
  • Put into practice things learnt from courses- eg MS MasterClass

More MS Academy Service development Projects

Navigating the Advanced MS Case Load from Fighting Fire to Quality Care
By Maria Grace Hazlett, MS Nurse Specialist, Central London Community Healthcare NHS Trust & Jody Barber, Lead MS Physiotherapist, Central London Community Healthcare NHS Trust
Setting up a Complex Disease Modifying Drug (DMD) Switching Clinic
By Aoife Shields, MS Principal Pharmacist, University College London Hospitals NHS Foundation Trust
MS service improvement project at ESHT
By Dr Monika Lipnicka-Khan, Consultant Neurologist, East Sussex Healthcare NHS Trust
Encouraging excellence, developing leaders, inspiring change

MS Academy was established five years ago and in that time has accomplished a huge amount. The six different levels of specialist MS training are dedicated to case-based learning and practical application of cutting edge research. Home to national programme Raising the Bar and the fantastic workstream content it is producing, this is an exciting Academy to belong to.